Global Swine Mycoplasma Hyopneumoniae Live Vaccine Supply, Demand and Key Producers, 2026-2032
The global Swine Mycoplasma Hyopneumoniae Live Vaccine market size is expected to reach $ 41.94 million by 2032, rising at a market growth of 5.0% CAGR during the forecast period (2026-2032).
Swine Mycoplasma Hyopneumoniae Live Vaccine is a preventive veterinary biological product formulated with live attenuated Mycoplasma hyopneumoniae strains, mainly used for the prevention of swine enzootic pneumonia, mycoplasmal pneumonia and related respiratory diseases in pigs. Commercial products are generally supplied as freeze-dried live vaccines, and the currently verifiable mainstream strain routes mainly include Strain 168 and Strain RM48, with administration routes such as intrapulmonary injection, intrathoracic injection and intranasal inoculation depending on product design. Upstream inputs mainly include production seed strains, specialized culture media, serum or serum substitutes, lyoprotectants, stabilizers, cultivation and harvesting consumables, vials or plastic bottles, rubber stoppers, aluminum caps, labels, cold-chain packaging materials and GMP-compliant biological manufacturing facilities. Downstream customers primarily include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors, animal disease prevention service providers and field veterinary service channels. Under a strict live-vaccine ex-factory scope, global effective production capacity in 2025 is estimated at about 218 million doses, with sales volume of about 151 million doses and an average ex-factory price of about USD 0.19 per dose. As commercialized supply is mainly concentrated in China, mainstream overseas Mycoplasma hyopneumoniae vaccines that are inactivated vaccines or combination vaccines are not included in this statistical scope. The industry gross margin in 2025 is estimated at around 45%–60%.
The current market is mainly centered on domestic production and application in China, and it remains a specialized segment within the veterinary vaccine industry. Supply is relatively concentrated, and demand mainly comes from large-scale pig farms, breeding farms and production systems with higher requirements for respiratory disease control. Compared with conventional inactivated vaccines, live vaccines place greater emphasis on respiratory local immunity and integrated herd-level disease prevention, giving them a stable application base in selected high-health-status farms.
Future development will focus more on administration convenience, product stability and adaptability to large-scale farming operations. As farming enterprises continue to pursue standardized vaccination programs, lower handling stress, reduced labor intensity and more consistent immune outcomes, products with easier administration, better field usability and stronger freeze-dried stability are expected to gain greater acceptance. Competition will increasingly depend on strain resources, manufacturing quality, field application evidence, technical service capability and farm-level solution design.
Market growth is mainly driven by the continued expansion of large-scale pig farming, stronger demand for integrated respiratory disease control, reduced antibiotic use and greater attention to production efficiency. Mycoplasma hyopneumoniae infection can interact with other pathogens and affect herd performance through coughing, lung lesions, slower growth and weaker feed conversion efficiency, so preventive vaccination remains an important part of stable pig production. When farm profitability improves and disease-control budgets recover, the penetration of this product category is expected to increase.
The main restraints include competition from substitute products, higher requirements for standardized use, hog cycle volatility and cost pressure at the farm level. Inactivated vaccines and combination vaccines have strong advantages in program integration, ease of use and channel coverage, so some farms may prefer simpler integrated immunization solutions. In addition, live vaccines require stricter cold-chain storage, reconstitution and administration practices, and improper execution may affect immune performance and repeat purchasing; during periods of weak hog prices, non-mandatory vaccine spending is also more likely to be reduced.
This report studies the global Swine Mycoplasma Hyopneumoniae Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Mycoplasma Hyopneumoniae Live Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Mycoplasma Hyopneumoniae Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Mycoplasma Hyopneumoniae Live Vaccine total production and demand, 2021-2032, (K Dose)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine total production value, 2021-2032, (USD Million)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Swine Mycoplasma Hyopneumoniae Live Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jofunhwa Group, Qianyuanhao Biological, Jilin Zhengye Biological Products, Qilu Animal Health Products, Shandong Lvdu Biotechnology, Guangdong Wens Dahuanong Biotechnology, Guangdong Winsun Bio-Pharmaceutical, Harbin Pharmaceutical Group Bio-vaccine, Wuhan Zhongbo Biotech, China Animal Husbandry Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Mycoplasma Hyopneumoniae Live Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Swine Mycoplasma Hyopneumoniae Live Vaccine Market, By Region:
1. How big is the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
2. What is the demand of the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
3. What is the year over year growth of the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
4. What is the production and production value of the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
5. Who are the key producers in the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
6. What are the growth factors driving the market demand?
Swine Mycoplasma Hyopneumoniae Live Vaccine is a preventive veterinary biological product formulated with live attenuated Mycoplasma hyopneumoniae strains, mainly used for the prevention of swine enzootic pneumonia, mycoplasmal pneumonia and related respiratory diseases in pigs. Commercial products are generally supplied as freeze-dried live vaccines, and the currently verifiable mainstream strain routes mainly include Strain 168 and Strain RM48, with administration routes such as intrapulmonary injection, intrathoracic injection and intranasal inoculation depending on product design. Upstream inputs mainly include production seed strains, specialized culture media, serum or serum substitutes, lyoprotectants, stabilizers, cultivation and harvesting consumables, vials or plastic bottles, rubber stoppers, aluminum caps, labels, cold-chain packaging materials and GMP-compliant biological manufacturing facilities. Downstream customers primarily include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors, animal disease prevention service providers and field veterinary service channels. Under a strict live-vaccine ex-factory scope, global effective production capacity in 2025 is estimated at about 218 million doses, with sales volume of about 151 million doses and an average ex-factory price of about USD 0.19 per dose. As commercialized supply is mainly concentrated in China, mainstream overseas Mycoplasma hyopneumoniae vaccines that are inactivated vaccines or combination vaccines are not included in this statistical scope. The industry gross margin in 2025 is estimated at around 45%–60%.
The current market is mainly centered on domestic production and application in China, and it remains a specialized segment within the veterinary vaccine industry. Supply is relatively concentrated, and demand mainly comes from large-scale pig farms, breeding farms and production systems with higher requirements for respiratory disease control. Compared with conventional inactivated vaccines, live vaccines place greater emphasis on respiratory local immunity and integrated herd-level disease prevention, giving them a stable application base in selected high-health-status farms.
Future development will focus more on administration convenience, product stability and adaptability to large-scale farming operations. As farming enterprises continue to pursue standardized vaccination programs, lower handling stress, reduced labor intensity and more consistent immune outcomes, products with easier administration, better field usability and stronger freeze-dried stability are expected to gain greater acceptance. Competition will increasingly depend on strain resources, manufacturing quality, field application evidence, technical service capability and farm-level solution design.
Market growth is mainly driven by the continued expansion of large-scale pig farming, stronger demand for integrated respiratory disease control, reduced antibiotic use and greater attention to production efficiency. Mycoplasma hyopneumoniae infection can interact with other pathogens and affect herd performance through coughing, lung lesions, slower growth and weaker feed conversion efficiency, so preventive vaccination remains an important part of stable pig production. When farm profitability improves and disease-control budgets recover, the penetration of this product category is expected to increase.
The main restraints include competition from substitute products, higher requirements for standardized use, hog cycle volatility and cost pressure at the farm level. Inactivated vaccines and combination vaccines have strong advantages in program integration, ease of use and channel coverage, so some farms may prefer simpler integrated immunization solutions. In addition, live vaccines require stricter cold-chain storage, reconstitution and administration practices, and improper execution may affect immune performance and repeat purchasing; during periods of weak hog prices, non-mandatory vaccine spending is also more likely to be reduced.
This report studies the global Swine Mycoplasma Hyopneumoniae Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Mycoplasma Hyopneumoniae Live Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Mycoplasma Hyopneumoniae Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Mycoplasma Hyopneumoniae Live Vaccine total production and demand, 2021-2032, (K Dose)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine total production value, 2021-2032, (USD Million)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Swine Mycoplasma Hyopneumoniae Live Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Swine Mycoplasma Hyopneumoniae Live Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jofunhwa Group, Qianyuanhao Biological, Jilin Zhengye Biological Products, Qilu Animal Health Products, Shandong Lvdu Biotechnology, Guangdong Wens Dahuanong Biotechnology, Guangdong Winsun Bio-Pharmaceutical, Harbin Pharmaceutical Group Bio-vaccine, Wuhan Zhongbo Biotech, China Animal Husbandry Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Mycoplasma Hyopneumoniae Live Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Swine Mycoplasma Hyopneumoniae Live Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Strain 168 Live Vaccine
- Strain RM48 Live Vaccine
- Others
- Intrapulmonary Injection
- Intrathoracic Injection
- Others
- Small Pack (Below 20 Doses per Vial)
- Medium Pack (20–50 Doses per Vial)
- Large Pack (Above 50 Doses per Vial)
- Large-scale Pig Farming Groups
- Breeding Pig Farms
- Animal Health Service Providers
- Others
- Jofunhwa Group
- Qianyuanhao Biological
- Jilin Zhengye Biological Products
- Qilu Animal Health Products
- Shandong Lvdu Biotechnology
- Guangdong Wens Dahuanong Biotechnology
- Guangdong Winsun Bio-Pharmaceutical
- Harbin Pharmaceutical Group Bio-vaccine
- Wuhan Zhongbo Biotech
- China Animal Husbandry Industry
1. How big is the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
2. What is the demand of the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
3. What is the year over year growth of the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
4. What is the production and production value of the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
5. Who are the key producers in the global Swine Mycoplasma Hyopneumoniae Live Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Introduction
1.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Supply & Forecast
1.2.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032)
1.2.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Pricing Trends (2021-2032)
1.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2021-2032)
1.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (2021-2032)
1.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Region (2021-2032)
1.3.4 China Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Mycoplasma Hyopneumoniae Live Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Demand (2021-2032)
2.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption by Region
2.2.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption by Region (2021-2026)
2.2.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.4 China Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.5 Europe Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.6 Japan Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.7 South Korea Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.8 ASEAN Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.9 India Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Manufacturer (2021-2026)
3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Manufacturer (2021-2026)
3.4 Swine Mycoplasma Hyopneumoniae Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Mycoplasma Hyopneumoniae Live Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Swine Mycoplasma Hyopneumoniae Live Vaccine in 2025
3.6 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Region Footprint
3.6.2 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Type Footprint
3.6.3 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Comparison
4.2.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026)
4.5 China Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026)
4.6 Rest of World Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Strain 168 Live Vaccine
5.2.2 Strain RM48 Live Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Type (2021-2032)
5.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type (2021-2032)
5.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Administration Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration Route
6.2.1 Intrapulmonary Injection
6.2.2 Intrathoracic Injection
6.2.3 Others
6.3 Market Segment by Administration Route
6.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Administration Route (2021-2032)
6.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route (2021-2032)
6.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2021-2032)
7 MARKET ANALYSIS BY DOSE PACK SIZE
7.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Dose Pack Size: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dose Pack Size
7.2.1 Small Pack (Below 20 Doses per Vial)
7.2.2 Medium Pack (20–50 Doses per Vial)
7.2.3 Large Pack (Above 50 Doses per Vial)
7.3 Market Segment by Dose Pack Size
7.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Dose Pack Size (2021-2032)
7.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size (2021-2032)
7.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large-scale Pig Farming Groups
8.2.2 Breeding Pig Farms
8.2.3 Animal Health Service Providers
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Application (2021-2032)
8.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application (2021-2032)
8.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Jofunhwa Group
9.1.1 Jofunhwa Group Details
9.1.2 Jofunhwa Group Major Business
9.1.3 Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.1.4 Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Jofunhwa Group Recent Developments/Updates
9.1.6 Jofunhwa Group Competitive Strengths & Weaknesses
9.2 Qianyuanhao Biological
9.2.1 Qianyuanhao Biological Details
9.2.2 Qianyuanhao Biological Major Business
9.2.3 Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.2.4 Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Qianyuanhao Biological Recent Developments/Updates
9.2.6 Qianyuanhao Biological Competitive Strengths & Weaknesses
9.3 Jilin Zhengye Biological Products
9.3.1 Jilin Zhengye Biological Products Details
9.3.2 Jilin Zhengye Biological Products Major Business
9.3.3 Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.3.4 Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Jilin Zhengye Biological Products Recent Developments/Updates
9.3.6 Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
9.4 Qilu Animal Health Products
9.4.1 Qilu Animal Health Products Details
9.4.2 Qilu Animal Health Products Major Business
9.4.3 Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.4.4 Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Qilu Animal Health Products Recent Developments/Updates
9.4.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
9.5 Shandong Lvdu Biotechnology
9.5.1 Shandong Lvdu Biotechnology Details
9.5.2 Shandong Lvdu Biotechnology Major Business
9.5.3 Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.5.4 Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Shandong Lvdu Biotechnology Recent Developments/Updates
9.5.6 Shandong Lvdu Biotechnology Competitive Strengths & Weaknesses
9.6 Guangdong Wens Dahuanong Biotechnology
9.6.1 Guangdong Wens Dahuanong Biotechnology Details
9.6.2 Guangdong Wens Dahuanong Biotechnology Major Business
9.6.3 Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.6.4 Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Guangdong Wens Dahuanong Biotechnology Recent Developments/Updates
9.6.6 Guangdong Wens Dahuanong Biotechnology Competitive Strengths & Weaknesses
9.7 Guangdong Winsun Bio-Pharmaceutical
9.7.1 Guangdong Winsun Bio-Pharmaceutical Details
9.7.2 Guangdong Winsun Bio-Pharmaceutical Major Business
9.7.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.7.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
9.7.6 Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
9.8 Harbin Pharmaceutical Group Bio-vaccine
9.8.1 Harbin Pharmaceutical Group Bio-vaccine Details
9.8.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
9.8.3 Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.8.4 Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
9.8.6 Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
9.9 Wuhan Zhongbo Biotech
9.9.1 Wuhan Zhongbo Biotech Details
9.9.2 Wuhan Zhongbo Biotech Major Business
9.9.3 Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.9.4 Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Wuhan Zhongbo Biotech Recent Developments/Updates
9.9.6 Wuhan Zhongbo Biotech Competitive Strengths & Weaknesses
9.10 China Animal Husbandry Industry
9.10.1 China Animal Husbandry Industry Details
9.10.2 China Animal Husbandry Industry Major Business
9.10.3 China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.10.4 China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 China Animal Husbandry Industry Recent Developments/Updates
9.10.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Chain
10.2 Swine Mycoplasma Hyopneumoniae Live Vaccine Upstream Analysis
10.2.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Swine Mycoplasma Hyopneumoniae Live Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Swine Mycoplasma Hyopneumoniae Live Vaccine Production Mode
10.6 Swine Mycoplasma Hyopneumoniae Live Vaccine Procurement Model
10.7 Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Sales Model and Sales Channels
10.7.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Sales Model
10.7.2 Swine Mycoplasma Hyopneumoniae Live Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Introduction
1.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Supply & Forecast
1.2.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032)
1.2.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Pricing Trends (2021-2032)
1.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2021-2032)
1.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (2021-2032)
1.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Region (2021-2032)
1.3.4 China Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Mycoplasma Hyopneumoniae Live Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Demand (2021-2032)
2.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption by Region
2.2.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption by Region (2021-2026)
2.2.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.4 China Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.5 Europe Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.6 Japan Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.7 South Korea Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.8 ASEAN Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
2.9 India Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Manufacturer (2021-2026)
3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Manufacturer (2021-2026)
3.4 Swine Mycoplasma Hyopneumoniae Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Mycoplasma Hyopneumoniae Live Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Swine Mycoplasma Hyopneumoniae Live Vaccine in 2025
3.6 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Region Footprint
3.6.2 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Type Footprint
3.6.3 Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Comparison
4.2.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026)
4.5 China Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026)
4.6 Rest of World Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Strain 168 Live Vaccine
5.2.2 Strain RM48 Live Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Type (2021-2032)
5.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type (2021-2032)
5.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION ROUTE
6.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Administration Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration Route
6.2.1 Intrapulmonary Injection
6.2.2 Intrathoracic Injection
6.2.3 Others
6.3 Market Segment by Administration Route
6.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Administration Route (2021-2032)
6.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route (2021-2032)
6.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2021-2032)
7 MARKET ANALYSIS BY DOSE PACK SIZE
7.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Dose Pack Size: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dose Pack Size
7.2.1 Small Pack (Below 20 Doses per Vial)
7.2.2 Medium Pack (20–50 Doses per Vial)
7.2.3 Large Pack (Above 50 Doses per Vial)
7.3 Market Segment by Dose Pack Size
7.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Dose Pack Size (2021-2032)
7.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size (2021-2032)
7.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large-scale Pig Farming Groups
8.2.2 Breeding Pig Farms
8.2.3 Animal Health Service Providers
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Application (2021-2032)
8.3.2 World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application (2021-2032)
8.3.3 World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Jofunhwa Group
9.1.1 Jofunhwa Group Details
9.1.2 Jofunhwa Group Major Business
9.1.3 Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.1.4 Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Jofunhwa Group Recent Developments/Updates
9.1.6 Jofunhwa Group Competitive Strengths & Weaknesses
9.2 Qianyuanhao Biological
9.2.1 Qianyuanhao Biological Details
9.2.2 Qianyuanhao Biological Major Business
9.2.3 Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.2.4 Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Qianyuanhao Biological Recent Developments/Updates
9.2.6 Qianyuanhao Biological Competitive Strengths & Weaknesses
9.3 Jilin Zhengye Biological Products
9.3.1 Jilin Zhengye Biological Products Details
9.3.2 Jilin Zhengye Biological Products Major Business
9.3.3 Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.3.4 Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Jilin Zhengye Biological Products Recent Developments/Updates
9.3.6 Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
9.4 Qilu Animal Health Products
9.4.1 Qilu Animal Health Products Details
9.4.2 Qilu Animal Health Products Major Business
9.4.3 Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.4.4 Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Qilu Animal Health Products Recent Developments/Updates
9.4.6 Qilu Animal Health Products Competitive Strengths & Weaknesses
9.5 Shandong Lvdu Biotechnology
9.5.1 Shandong Lvdu Biotechnology Details
9.5.2 Shandong Lvdu Biotechnology Major Business
9.5.3 Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.5.4 Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Shandong Lvdu Biotechnology Recent Developments/Updates
9.5.6 Shandong Lvdu Biotechnology Competitive Strengths & Weaknesses
9.6 Guangdong Wens Dahuanong Biotechnology
9.6.1 Guangdong Wens Dahuanong Biotechnology Details
9.6.2 Guangdong Wens Dahuanong Biotechnology Major Business
9.6.3 Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.6.4 Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Guangdong Wens Dahuanong Biotechnology Recent Developments/Updates
9.6.6 Guangdong Wens Dahuanong Biotechnology Competitive Strengths & Weaknesses
9.7 Guangdong Winsun Bio-Pharmaceutical
9.7.1 Guangdong Winsun Bio-Pharmaceutical Details
9.7.2 Guangdong Winsun Bio-Pharmaceutical Major Business
9.7.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.7.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
9.7.6 Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
9.8 Harbin Pharmaceutical Group Bio-vaccine
9.8.1 Harbin Pharmaceutical Group Bio-vaccine Details
9.8.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
9.8.3 Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.8.4 Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
9.8.6 Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
9.9 Wuhan Zhongbo Biotech
9.9.1 Wuhan Zhongbo Biotech Details
9.9.2 Wuhan Zhongbo Biotech Major Business
9.9.3 Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.9.4 Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Wuhan Zhongbo Biotech Recent Developments/Updates
9.9.6 Wuhan Zhongbo Biotech Competitive Strengths & Weaknesses
9.10 China Animal Husbandry Industry
9.10.1 China Animal Husbandry Industry Details
9.10.2 China Animal Husbandry Industry Major Business
9.10.3 China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
9.10.4 China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 China Animal Husbandry Industry Recent Developments/Updates
9.10.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Chain
10.2 Swine Mycoplasma Hyopneumoniae Live Vaccine Upstream Analysis
10.2.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Swine Mycoplasma Hyopneumoniae Live Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Swine Mycoplasma Hyopneumoniae Live Vaccine Production Mode
10.6 Swine Mycoplasma Hyopneumoniae Live Vaccine Procurement Model
10.7 Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Sales Model and Sales Channels
10.7.1 Swine Mycoplasma Hyopneumoniae Live Vaccine Sales Model
10.7.2 Swine Mycoplasma Hyopneumoniae Live Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Region (2021-2026)
Table 9. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Region (2027-2032)
Table 10. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Swine Mycoplasma Hyopneumoniae Live Vaccine Major Market Trends
Table 13. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Swine Mycoplasma Hyopneumoniae Live Vaccine Producers in 2025
Table 18. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Swine Mycoplasma Hyopneumoniae Live Vaccine Producers in 2025
Table 20. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Swine Mycoplasma Hyopneumoniae Live Vaccine Company Evaluation Quadrant
Table 22. World Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Swine Mycoplasma Hyopneumoniae Live Vaccine Production Site of Key Manufacturer
Table 24. Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Type Footprint
Table 25. Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Application Footprint
Table 26. Swine Mycoplasma Hyopneumoniae Live Vaccine Competitive Factors
Table 27. Swine Mycoplasma Hyopneumoniae Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Mycoplasma Hyopneumoniae Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Swine Mycoplasma Hyopneumoniae Live Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share (2021-2026)
Table 37. China Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share (2021-2026)
Table 47. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Administration Route (2021-2026) & (K Dose)
Table 56. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Administration Route (2027-2032) & (K Dose)
Table 57. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route (2021-2026) & (USD Million)
Table 58. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route (2027-2032) & (USD Million)
Table 59. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2021-2026) & (US$/Dose)
Table 60. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2027-2032) & (US$/Dose)
Table 61. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 62. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Dose Pack Size (2021-2026) & (K Dose)
Table 63. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Dose Pack Size (2027-2032) & (K Dose)
Table 64. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size (2021-2026) & (USD Million)
Table 65. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size (2027-2032) & (USD Million)
Table 66. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 67. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2027-2032) & (US$/Dose)
Table 68. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Jofunhwa Group Basic Information, Manufacturing Base and Competitors
Table 76. Jofunhwa Group Major Business
Table 77. Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 78. Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Jofunhwa Group Recent Developments/Updates
Table 80. Jofunhwa Group Competitive Strengths & Weaknesses
Table 81. Qianyuanhao Biological Basic Information, Manufacturing Base and Competitors
Table 82. Qianyuanhao Biological Major Business
Table 83. Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 84. Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Qianyuanhao Biological Recent Developments/Updates
Table 86. Qianyuanhao Biological Competitive Strengths & Weaknesses
Table 87. Jilin Zhengye Biological Products Basic Information, Manufacturing Base and Competitors
Table 88. Jilin Zhengye Biological Products Major Business
Table 89. Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 90. Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Jilin Zhengye Biological Products Recent Developments/Updates
Table 92. Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
Table 93. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 94. Qilu Animal Health Products Major Business
Table 95. Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 96. Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Qilu Animal Health Products Recent Developments/Updates
Table 98. Qilu Animal Health Products Competitive Strengths & Weaknesses
Table 99. Shandong Lvdu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 100. Shandong Lvdu Biotechnology Major Business
Table 101. Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 102. Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Shandong Lvdu Biotechnology Recent Developments/Updates
Table 104. Shandong Lvdu Biotechnology Competitive Strengths & Weaknesses
Table 105. Guangdong Wens Dahuanong Biotechnology Basic Information, Manufacturing Base and Competitors
Table 106. Guangdong Wens Dahuanong Biotechnology Major Business
Table 107. Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 108. Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Guangdong Wens Dahuanong Biotechnology Recent Developments/Updates
Table 110. Guangdong Wens Dahuanong Biotechnology Competitive Strengths & Weaknesses
Table 111. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 113. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 114. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 116. Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 117. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 118. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 119. Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 120. Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 122. Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
Table 123. Wuhan Zhongbo Biotech Basic Information, Manufacturing Base and Competitors
Table 124. Wuhan Zhongbo Biotech Major Business
Table 125. Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 126. Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Wuhan Zhongbo Biotech Recent Developments/Updates
Table 128. Wuhan Zhongbo Biotech Competitive Strengths & Weaknesses
Table 129. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 130. China Animal Husbandry Industry Major Business
Table 131. China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 132. China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. China Animal Husbandry Industry Recent Developments/Updates
Table 134. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 135. Global Key Players of Swine Mycoplasma Hyopneumoniae Live Vaccine Upstream (Raw Materials)
Table 136. Global Swine Mycoplasma Hyopneumoniae Live Vaccine Typical Customers
Table 137. Swine Mycoplasma Hyopneumoniae Live Vaccine Typical Distributors
Table 1. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Region (2021-2026)
Table 9. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Region (2027-2032)
Table 10. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Swine Mycoplasma Hyopneumoniae Live Vaccine Major Market Trends
Table 13. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Swine Mycoplasma Hyopneumoniae Live Vaccine Producers in 2025
Table 18. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Swine Mycoplasma Hyopneumoniae Live Vaccine Producers in 2025
Table 20. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Swine Mycoplasma Hyopneumoniae Live Vaccine Company Evaluation Quadrant
Table 22. World Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Swine Mycoplasma Hyopneumoniae Live Vaccine Production Site of Key Manufacturer
Table 24. Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Type Footprint
Table 25. Swine Mycoplasma Hyopneumoniae Live Vaccine Market: Company Product Application Footprint
Table 26. Swine Mycoplasma Hyopneumoniae Live Vaccine Competitive Factors
Table 27. Swine Mycoplasma Hyopneumoniae Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Mycoplasma Hyopneumoniae Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Swine Mycoplasma Hyopneumoniae Live Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share (2021-2026)
Table 37. China Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Swine Mycoplasma Hyopneumoniae Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share (2021-2026)
Table 47. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Administration Route (2021-2026) & (K Dose)
Table 56. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Administration Route (2027-2032) & (K Dose)
Table 57. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route (2021-2026) & (USD Million)
Table 58. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route (2027-2032) & (USD Million)
Table 59. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2021-2026) & (US$/Dose)
Table 60. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2027-2032) & (US$/Dose)
Table 61. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 62. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Dose Pack Size (2021-2026) & (K Dose)
Table 63. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Dose Pack Size (2027-2032) & (K Dose)
Table 64. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size (2021-2026) & (USD Million)
Table 65. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size (2027-2032) & (USD Million)
Table 66. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 67. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2027-2032) & (US$/Dose)
Table 68. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Jofunhwa Group Basic Information, Manufacturing Base and Competitors
Table 76. Jofunhwa Group Major Business
Table 77. Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 78. Jofunhwa Group Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Jofunhwa Group Recent Developments/Updates
Table 80. Jofunhwa Group Competitive Strengths & Weaknesses
Table 81. Qianyuanhao Biological Basic Information, Manufacturing Base and Competitors
Table 82. Qianyuanhao Biological Major Business
Table 83. Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 84. Qianyuanhao Biological Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Qianyuanhao Biological Recent Developments/Updates
Table 86. Qianyuanhao Biological Competitive Strengths & Weaknesses
Table 87. Jilin Zhengye Biological Products Basic Information, Manufacturing Base and Competitors
Table 88. Jilin Zhengye Biological Products Major Business
Table 89. Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 90. Jilin Zhengye Biological Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Jilin Zhengye Biological Products Recent Developments/Updates
Table 92. Jilin Zhengye Biological Products Competitive Strengths & Weaknesses
Table 93. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 94. Qilu Animal Health Products Major Business
Table 95. Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 96. Qilu Animal Health Products Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Qilu Animal Health Products Recent Developments/Updates
Table 98. Qilu Animal Health Products Competitive Strengths & Weaknesses
Table 99. Shandong Lvdu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 100. Shandong Lvdu Biotechnology Major Business
Table 101. Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 102. Shandong Lvdu Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Shandong Lvdu Biotechnology Recent Developments/Updates
Table 104. Shandong Lvdu Biotechnology Competitive Strengths & Weaknesses
Table 105. Guangdong Wens Dahuanong Biotechnology Basic Information, Manufacturing Base and Competitors
Table 106. Guangdong Wens Dahuanong Biotechnology Major Business
Table 107. Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 108. Guangdong Wens Dahuanong Biotechnology Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Guangdong Wens Dahuanong Biotechnology Recent Developments/Updates
Table 110. Guangdong Wens Dahuanong Biotechnology Competitive Strengths & Weaknesses
Table 111. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 113. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 114. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 116. Guangdong Winsun Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 117. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 118. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 119. Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 120. Harbin Pharmaceutical Group Bio-vaccine Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 122. Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
Table 123. Wuhan Zhongbo Biotech Basic Information, Manufacturing Base and Competitors
Table 124. Wuhan Zhongbo Biotech Major Business
Table 125. Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 126. Wuhan Zhongbo Biotech Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Wuhan Zhongbo Biotech Recent Developments/Updates
Table 128. Wuhan Zhongbo Biotech Competitive Strengths & Weaknesses
Table 129. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 130. China Animal Husbandry Industry Major Business
Table 131. China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Product and Services
Table 132. China Animal Husbandry Industry Swine Mycoplasma Hyopneumoniae Live Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. China Animal Husbandry Industry Recent Developments/Updates
Table 134. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 135. Global Key Players of Swine Mycoplasma Hyopneumoniae Live Vaccine Upstream (Raw Materials)
Table 136. Global Swine Mycoplasma Hyopneumoniae Live Vaccine Typical Customers
Table 137. Swine Mycoplasma Hyopneumoniae Live Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Swine Mycoplasma Hyopneumoniae Live Vaccine Picture
Figure 2. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Region (2021-2032)
Figure 8. China Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032) & (K Dose)
Figure 9. Swine Mycoplasma Hyopneumoniae Live Vaccine Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 12. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Market Share by Region (2021-2032)
Figure 13. United States Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 14. China Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. Europe Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. Japan Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. South Korea Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. ASEAN Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. India Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. Producer Shipments of Swine Mycoplasma Hyopneumoniae Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 21. Global Four-firm Concentration Ratios (CR4) for Swine Mycoplasma Hyopneumoniae Live Vaccine Markets in 2025
Figure 22. Global Four-firm Concentration Ratios (CR8) for Swine Mycoplasma Hyopneumoniae Live Vaccine Markets in 2025
Figure 23. United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 24. United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 25. United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share 2025
Figure 27. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share 2025
Figure 28. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share 2025
Figure 29. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Type in 2025
Figure 31. Strain 168 Live Vaccine
Figure 32. Strain RM48 Live Vaccine
Figure 33. Others
Figure 34. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Type (2021-2032)
Figure 35. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Type (2021-2032)
Figure 36. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 37. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 38. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Administration Route in 2025
Figure 39. Intrapulmonary Injection
Figure 40. Intrathoracic Injection
Figure 41. Others
Figure 42. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Administration Route (2021-2032)
Figure 43. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Administration Route (2021-2032)
Figure 44. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2021-2032) & (US$/Dose)
Figure 45. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 46. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Dose Pack Size in 2025
Figure 47. Small Pack (Below 20 Doses per Vial)
Figure 48. Medium Pack (20–50 Doses per Vial)
Figure 49. Large Pack (Above 50 Doses per Vial)
Figure 50. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Dose Pack Size (2021-2032)
Figure 51. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Dose Pack Size (2021-2032)
Figure 52. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2021-2032) & (US$/Dose)
Figure 53. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Application in 2025
Figure 55. Large-scale Pig Farming Groups
Figure 56. Breeding Pig Farms
Figure 57. Animal Health Service Providers
Figure 58. Others
Figure 59. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Application (2021-2032)
Figure 60. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Application (2021-2032)
Figure 61. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 62. Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Chain
Figure 63. Swine Mycoplasma Hyopneumoniae Live Vaccine Procurement Model
Figure 64. Swine Mycoplasma Hyopneumoniae Live Vaccine Sales Model
Figure 65. Swine Mycoplasma Hyopneumoniae Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
Figure 1. Swine Mycoplasma Hyopneumoniae Live Vaccine Picture
Figure 2. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Region (2021-2032)
Figure 8. China Swine Mycoplasma Hyopneumoniae Live Vaccine Production (2021-2032) & (K Dose)
Figure 9. Swine Mycoplasma Hyopneumoniae Live Vaccine Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 12. World Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Market Share by Region (2021-2032)
Figure 13. United States Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 14. China Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. Europe Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 16. Japan Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. South Korea Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. ASEAN Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. India Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. Producer Shipments of Swine Mycoplasma Hyopneumoniae Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 21. Global Four-firm Concentration Ratios (CR4) for Swine Mycoplasma Hyopneumoniae Live Vaccine Markets in 2025
Figure 22. Global Four-firm Concentration Ratios (CR8) for Swine Mycoplasma Hyopneumoniae Live Vaccine Markets in 2025
Figure 23. United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 24. United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 25. United States VS China: Swine Mycoplasma Hyopneumoniae Live Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share 2025
Figure 27. China Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share 2025
Figure 28. Rest of World Based Manufacturers Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share 2025
Figure 29. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Type in 2025
Figure 31. Strain 168 Live Vaccine
Figure 32. Strain RM48 Live Vaccine
Figure 33. Others
Figure 34. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Type (2021-2032)
Figure 35. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Type (2021-2032)
Figure 36. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 37. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 38. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Administration Route in 2025
Figure 39. Intrapulmonary Injection
Figure 40. Intrathoracic Injection
Figure 41. Others
Figure 42. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Administration Route (2021-2032)
Figure 43. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Administration Route (2021-2032)
Figure 44. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Administration Route (2021-2032) & (US$/Dose)
Figure 45. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 46. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Dose Pack Size in 2025
Figure 47. Small Pack (Below 20 Doses per Vial)
Figure 48. Medium Pack (20–50 Doses per Vial)
Figure 49. Large Pack (Above 50 Doses per Vial)
Figure 50. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Dose Pack Size (2021-2032)
Figure 51. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Dose Pack Size (2021-2032)
Figure 52. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Dose Pack Size (2021-2032) & (US$/Dose)
Figure 53. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Application in 2025
Figure 55. Large-scale Pig Farming Groups
Figure 56. Breeding Pig Farms
Figure 57. Animal Health Service Providers
Figure 58. Others
Figure 59. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Market Share by Application (2021-2032)
Figure 60. World Swine Mycoplasma Hyopneumoniae Live Vaccine Production Value Market Share by Application (2021-2032)
Figure 61. World Swine Mycoplasma Hyopneumoniae Live Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 62. Swine Mycoplasma Hyopneumoniae Live Vaccine Industry Chain
Figure 63. Swine Mycoplasma Hyopneumoniae Live Vaccine Procurement Model
Figure 64. Swine Mycoplasma Hyopneumoniae Live Vaccine Sales Model
Figure 65. Swine Mycoplasma Hyopneumoniae Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
